Spotlight on the impacts of transfusion on patients with Autoimmune Rheumatic Diseases

Published:October 31, 2022DOI:
      The main objective of the What’s Happening Section of TRASCI is to encourage team working, to collectively bring today what will be tomorrow’s news. In the current bimonthly issue, and as the follow up of our previous “joint ventures” on clinical and laboratory themes, I have invited Professor Hadi Goubran, Saskatoon Cancer Centre and College of Medicine, University of Saskatchewan, Saskatoon, Canada to lead a systematic synthesis of the latest opinions on the current guidelines-based, and consequential treatments of choice, on a topic of interest to all contributors and readers alike: “Blood Transfusion in Autoimmune Rheumatic Diseases”.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect